Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICON: Neoadjuvant Chemotherapy in Early Stage NSCLC
NCT00329472Phase 3Withdrawn
- Sponsor
- Samsung Medical Center
- Start
- Apr 2006
- Primary completion
- Jul 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of gemcitabine, cisplatin in non-small cell lung cancer (NSCLC), sponsored by Samsung Medical Center. Planned start Apr 2006; status: withdrawn.
02
Drugs
gemcitabinecisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00329472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00329472.